19-epi-okadaic acid, a novel protein phosphatase inhibitor with enhanced selectivity

Organic Letters

Volumn 9, Issue 16, 2007, Pages 3045-3048

  Cruz, Patricia G ^a   Daranas, Antonio Hernández ^a   Fernández, José J ^a   Norte, Manuel ^a  

^a UNIVERSIDAD DE LA LAGUNA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

19 EPI OKADAIC ACID; 19-EPI-OKADAIC ACID; DRUG DERIVATIVE; ENZYME INHIBITOR; OKADAIC ACID; PHOSPHOPROTEIN PHOSPHATASE; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; CONFORMATION; DINOFLAGELLATE; DRUG ANTAGONISM; ISOLATION AND PURIFICATION; NUCLEAR MAGNETIC RESONANCE; X RAY CRYSTALLOGRAPHY;

ANIMALS; CRYSTALLOGRAPHY, X-RAY; DINOFLAGELLIDA; ENZYME INHIBITORS; MOLECULAR CONFORMATION; MOLECULAR STRUCTURE; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; OKADAIC ACID; PHOSPHOPROTEIN PHOSPHATASE;

EID: 34547942018     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol071099i     Document Type: Article

References (27)

1. Daranas, A. H.; Norte, M.; Fernández, J. J. Toxicon 2001, 39, 1101-1132.
2. Yasumoto, T.; Murata, M.; Oshima, Y.; Sano, M.; Matsumoto, G. K.; Clardy, J. Tetrahedron 1985, 41, 1019-1025.
3. Suganuma, M.; Fujiki, H.; Suguri, H.; Yoshizawa, S.; Hirota, M.; Nakayasu, M.; Ojiva, M.; Wakamatsu, K.; Yamada, K.; Sugimura, T. Proc. Nati. Acad. Sci. U.S.A. 1988, 85, 1768-1771.
4. Biolojan, C.; Takai, A. Biochem. J. 1988, 256, 283-290.
5. McCluskey, A.; Sim, T. R.; Sakoff, J. A. J. Med. Chem. 2002, 45, 1151-1175.
6. Fernández, J. J.; Candenas, M. L.; Souto, M. L.; Trujillo, M. M.; Norte, M. Curr. Med. Chem. 2002, 9, 229-262.
7. Daranas, A. H.; Fernández, J. J.; Norte, M.; Gavin, J. A.; Suárez-Gómez, B.; Souto, M. L. Chem. Rec. 2004, 4, 1-9.
8. (a) Isobe, M.; Ichikawa, Y.; Goto, T. Tetrahedron Lett. 1986, 27, 963-966.
9. (b) Forsyth, C. J.; Sabes, S. F.; Urbanek, R. A. J. Am. Chem. Soc. 1997, 119, 8381-8382.
10. (c) Ley, S. V.; Humphries, A. C.; Eick, H.; Downhan, R.; Ross, A. R.; Boyce, R. J.; Pavey, J. B. J.; Pietruszka, J. J. Chem. Soc., Perkin Trans. 1 1998, 3907-3912.
11. Daranas, A. H.; Fernández, J. J.; Morales, E. Q.; Norte, M.; Gavín, J. A. J. Med. Chem. 2004, 47, 10-13.
12. NMR experiments were acquired in deuterated methanol at 400 and 500 MHz at a temperature of 298 K. HSQC, COSY, 1D/2D TOCSY, HMBC, and ROESY experiments were performed using standard pulse sequences. Data were processed using MestRec software. The volume integrals of the individually assigned NOE cross-peaks were converted into distance constrains using the isolated spin pair approximation, taking into account the offset effect.
13. Neuhaus, D.; Willianson, M. P. In The Nuclear Overhauser Effect in Structural and Conformational Analysis, 2nd ed.; Wiley-VCH: New York, 2000; pp 485-550.
14. Tachibana, K.; Scheuer, P. J.; Tsukitani, Y.; Kikuchi, H.; Van Engen, D.; Clardy, J.; Gopichand, Y.; Schmitz, F. J. J. Am. Chem. Soc. 1981, 103, 2469-2471.
15. Allinger, N. L.; Yuh, Y. H.; Lii, J. H. J. Am. Chem. Soc. 1989, 111, 8551-8559.
16. Halgren, T. A. J. Comput. Chem. 1996, 17, 490-519.
17. Mohamadi, F.; Richards, N. G. J.; Guida, W. C.; Liskamp, R.; Lipton, M.; Caufield, C.; Chang, G.; Hendrickson, T.; Still, W. C. J. Comput. Chem. 1990, 11, 440-467.
18. Still, W. C. T.; Tempczyk, A.; Hawley, R. C.; Hendrickson, T. J. Am. Chem. Soc 1990, 112, 6127-6129.
19. Thepchatri, P.; Cicero, D. O.; Monteagudo, E.; Ghosh, A. K.; Cornett, B.; Weeks, E. R.; Snyder, J. P. J. Am. Chem. Soc. 2005, 127, 12838-12846.
20. Uemura, D. Bioactive polyethers. In Biorganic Marine Chemistry; Scheuer, P. J., Ed.; Springer-Verlag: New York, 1991; Vol. 4, pp 1-31.
21. Vieytes, J. M.; Fontal, O. I.; Leira, F.; Baptista de Sousa, J. M. V.; Botana, L. M. Anal. Biochem. 1997, 248, 258-264.
22. PP1c was purchased from New England Biolabs, and PP2Ac was purchased from Sigma. Protein phosphatase activity was assayed at 37°C using 0.025 units/μL of protein and 100 μM of fluorescein diphosphate as substrate. The reaction was followed by fluorescence spectroscopy at 485-535 nM. Data were fitted to a one-site binding model. Assays with 19-epi-okadaic acid were performed in quintuplicate (n = 5), while for okadaic acid only duplicates (n = 2) were used.
23. Assays adding BSA (0.125 mg/mL) to the media were also undertaken in order to explore the possibility that 19-epi-OA could be a "phony" hit as described in McGovern, S. L.; Caselli, E.; Grigorieff, N.; Shoichet, B. K. J. Med. Chem. 2002, 45, 1712-1722, but no significant differences were seen, leaving out such possibility.
24. Colby, D. A.; Chamberlin, A. R. Mini-Rev. Med. Chem. 2006, 6, 657-665.
25. Maynes, J. T.; Luu, H. A.; Cherney, M. M.; Andersen, R. J.; Williams, D.; Holmes, C. F. B.; James, M. N. G. J. Mol. Biol. 2006, 356, 111-120.
26. Maynes, J. T.; Bateman, K. S.; Cherney, M. M.; Das, A. K.; Luu, A. H.; Holmes, C. F. B.; James, M. N. G. J. Biol. Chem. 2001, 276, 44078-44082.
27. Xing, Y.; Xu, Y.; Chen, Y.; Jeffrey, P. D.; Chao, Y.; Lin, Z.; Li, Z.; Strack, S.; Stock, J. B.; Shi, Y. Cell 2006, 127, 341-353.